US FDA approves J&J's bladder cancer treatment

Core Viewpoint - The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for patients with a type of bladder cancer, providing a potential alternative to surgical removal of the organ [1] Company Summary - Johnson & Johnson has received FDA approval for a new drug delivery system aimed at treating bladder cancer [1] Industry Summary - The approval of this drug delivery system represents a significant advancement in the treatment options available for bladder cancer patients, potentially reducing the need for invasive surgical procedures [1]